Bridgeway Capital Management, LLC Maia Biotechnology, Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.44 Billion
- Q3 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 45,700 shares of MAIA stock, worth $94,598. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,700
Previous 45,700
-0.0%
Holding current value
$94,598
Previous $156,000
17.95%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MAIA
# of Institutions
18Shares Held
1.47MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA566KShares$1.17 Million0.0% of portfolio
-
Halter Ferguson Financial Inc. Carmel, IN377KShares$779,7970.56% of portfolio
-
Geode Capital Management, LLC Boston, MA193KShares$398,6050.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$162,5380.0% of portfolio
-
Centric Wealth Management68.2KShares$141,2130.05% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $22.6M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...